Routine Plasma Level Determination to Compare Actual vs Expected Plasma Levels at Psychiatric Inpatient Admission
NCT00627510 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 161
Last updated 2008-03-03
Summary
Compliance with treatment is notoriously low in psychiatric patients. Traditional methods of monitoring compliance, however, may underreport nonadherence to treatment. In this study, actual plasma levels at admission - which are ROUTINELY taken at the Dept Psychiatry of the Paracelsus Medical University - were compared to plasma levels that can be expected from the prescribed preadmission dosing regimen. This was done to give treating psychiatrists a quantitatively precise idea of how frequently they can expect their patients to have plasma levels that are below the level of medication as intended by the prescribing physician.
Conditions
- Depression
- Affective Disorders, Psychotic
Interventions
- OTHER
-
Routine psychiatric inpatient treatment
Routine psychiatric inpatient treatment. This is not an interventional study.
Sponsors & Collaborators
-
Medical University Innsbruck
lead OTHER
Principal Investigators
-
Gerald Zernig, MD · Medical University Innsbruck
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-06-30
- Primary Completion
- 2005-07-31
- Completion
- 2007-12-31
Countries
- Austria
Study Locations
More Related Trials
-
Medication Adherence in Older Adults With Serious Mental Illness
NCT00224380 ·Status: COMPLETED ·Phase: NA
-
Examining Persistence in Smokers With Schizophrenia
NCT03346291 ·Status: COMPLETED ·Phase: NA
-
Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting
NCT00932529 ·Status: COMPLETED ·Phase: PHASE4
-
An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder
NCT00861003 ·Status: UNKNOWN
-
Motivational Interviewing for Patients With Acute Psychosis
NCT05911529 ·Status: COMPLETED ·Phase: NA
-
Implementation of National Guidelines for Treatment of Psychoses
NCT03271242 ·Status: COMPLETED
-
Clinical Intervention Psychosis and Addiction
NCT01411566 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder
NCT01769014 ·Status: UNKNOWN
-
Evaluation of Home Treatment for Acute Psychiatric Care
NCT03320720 ·Status: UNKNOWN ·Phase: NA
-
Prepulse Inhibition (PPI) of Startle Reflex in Schizophrenia Patients Related to Type of Treatment and Illness Duration
NCT02484521 ·Status: COMPLETED ·Phase: NA
-
Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics.
NCT01786369 ·Status: COMPLETED
-
Assessment of the Efficacy of a Fatigue Management Therapy in Schizophrenia
NCT04332601 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
"Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients"
NCT03149107 ·Status: TERMINATED ·Phase: PHASE3
-
The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.
NCT05958875 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of an Acceptance-based Medication Adherence Therapy for Recent-onset Psychosis
NCT06192602 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Measuring the Effect of Remote Monitoring of Treatment Adherence on the Risk of Re-admission of Ambulatory Schizophrenic Patients
NCT01729572 ·Status: UNKNOWN ·Phase: NA
-
Assessment of Efficacy of a Psychological Therapy in Inpatients With a Schizophrenic Psychosis
NCT03316664 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia
NCT00654576 ·Status: COMPLETED ·Phase: PHASE4
-
Phenomics and Genomics of Clozapine Pharmacotherapy
NCT03253367 ·Status: UNKNOWN
-
Serotonin 1A Agonists and Cognition in Schizophrenia
NCT00178971 ·Status: COMPLETED ·Phase: PHASE3
-
The Significance of Deviation in Time From the 12-hour Standard Serum-clozapine Monitoring.
NCT02625103 ·Status: COMPLETED ·Phase: PHASE4
-
Feasibility of an Early Detection Program for Early Psychosis on a College Campus
NCT03983421 ·Status: COMPLETED
-
Intervention Targeting Motivational Negative Symptoms
NCT04325100 ·Status: COMPLETED ·Phase: NA
-
Inpatient Group Acceptance and Commitment Therapy (ACT) for Psychosis Spectrum Disorder
NCT06086184 ·Status: RECRUITING ·Phase: NA
-
Predictors of Functional Remission in Discharged Patients With Schizophrenia After Long-term Drug Discontinuation
NCT05667961 ·Status: COMPLETED